Results 1 to 10 of about 2,402,468 (250)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States [PDF]

Drug and Alcohol Dependence Reports, 2023
Research objective: Medication opioid use disorder (MOUD) treatment is the first-line approach to the treatment of opioid use disorder (OUD). This analysis seeks to identify “critical access” MOUD facilities that ensure geographic access for MOUD ...
Harold A. Pollack, Francis Lee, Susan Paykin, Javier Andres Rojas Aguilera   +3 more
doaj   +6 more sources

Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program [PDF]

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Medication for opioid use disorder (MOUD) is the gold standard treatment for opioid use disorder. Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other ...
Megan K. Reed, Kelsey R. Smith, Francesca Ciocco, Richard W. Hass, Avery Lin Cox, Erin L. Kelly, Lara C. Weinstein   +6 more
doaj   +8 more sources

Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model [PDF]

Implementation Research and Practice, 2023
Background Access to providers and programs that provide medications for opioid use disorder (MOUD) remains a systemic barrier for patients with opioid use disorder (OUD), particularly if they live in rural areas.
Renee M. Cloutier, Evan S. Cole, Brianna L. McDonough, Daniel A. Lomauro, John P. Miller, Abigail L. Talbert, Todd M. Bear, Nora C. Bridges, Abigail L. Foulds, Rachel Taber, Adam J. Gordon, Gerald T. Cochran, Julie Kmiec, Julie M. Donohue, David Kelley, Ellen DiDomenico, Dale Adair, Janice L. Pringle   +17 more
doaj   +5 more sources

The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl [PDF]

Harm Reduction Journal
Background Fentanyl and fentanyl analogues have disrupted the illicit drug supply through contamination of other substances (i.e., methamphetamine and cocaine) and replacement of heroin in illicit markets.
Maria Bolshakova, Kelsey A. Simpson, Siddhi S. Ganesh, Jesse L. Goldshear, Cheyenne J. Page, Ricky N. Bluthenthal   +5 more
doaj   +6 more sources

Assessing Loneliness among Adults Receiving Outpatient Treatment with Medication for Opioid Use Disorder (MOUD). [PDF]

Int J Environ Res Public Health, 2022
Loneliness is a significant risk factor for substance use, however, impacts of treatments on loneliness are relatively unexplored. Living in a rural location is a greater risk factor for loneliness. This study examined data from a quasi-experimental study in rural Appalachia, comparing the effectiveness of Mindfulness-Based Relapse Prevention (MBRP ...
Mills R, Zullig KJ, Theeke LA, Lander LR, Hobbs GR, Herczyk J, Davis SM.   +6 more
europepmc   +5 more sources

Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the New Hampshire Department of Corrections (NHDOC) [PDF]

Health & Justice
Introduction Expanding access to medication for opioid use disorder (MOUD) to people involved in the carceral system is a priority for the New Hampshire Department of Corrections (NHDOC), where more than 40% of residents have an opioid use disorder (OUD).
Nancy Clayman, Pracha Eamranond, Helen Hanks, Michael Mitcheff, Lisa RappaMannion, Diane York, Paula Mattis, Heidi Guinen, Alex Carp, Laura Olson, Kathleen Bell, Lydia Shahi, Elizabeth Saunders, Joshua Lee, Lisa Marsch   +14 more
doaj   +3 more sources

The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. [PDF]

Drug Alcohol Depend, 2022
In March 2020, Veterans Health Administration (VHA) enacted policies to expand treatment for Veterans with opioid use disorder (OUD) during COVID-19. In this study, we evaluate whether COVID-19 and subsequent OUD treatment policies impacted receipt of therapy/counseling and medication for OUD (MOUD).Using VHA's nationwide electronic health record data,
Livingston NA, Davenport M, Head M, Henke R, LeBeau LS, Gibson TB, Banducci AN, Sarpong A, Jayanthi S, Roth C, Camacho-Cook J, Meng F, Hyde J, Mulvaney-Day N, White M, Chen DC, Stein MD, Weisberg R.   +17 more
europepmc   +4 more sources

Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial [PDF]

Addiction Science & Clinical Practice, 2021
Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities.
Yih-Ing Hser, Allison J. Ober, Alex R. Dopp, Chunqing Lin, Katie P. Osterhage, Sarah E. Clingan, Larissa J. Mooney, Megan E. Curtis, Lisa A. Marsch, Bethany McLeman, Emily Hichborn, Laurie S. Lester, Laura-Mae Baldwin, Yanping Liu, Petra Jacobs, Andrew J. Saxon   +15 more
doaj   +3 more sources

A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence [PDF]

Contemporary Clinical Trials Communications, 2022
Background: There is an unmet need for non-medication approaches to illicit opioid discontinuation and relapse prevention. The NET (NeuroElectric Therapy) Device is a non-invasive, battery-operated, portable, re-useable device designed to deliver ...
Mark K. Greenwald, Samiran Ghosh, Joe R. Winston   +2 more
doaj   +3 more sources

Using machine learning to study the effect of medication adherence in Opioid Use Disorder [PDF]

PLoS ONE, 2022
Background Opioid Use Disorder (OUD) and opioid overdose (OD) impose huge social and economic burdens on society and health care systems. Research suggests that Medication for Opioid Use Disorder (MOUD) is effective in the treatment of OUD.
David Warren, Amir Marashi, Arwa Siddiqui, Asim Adnan Eijaz, Pooja Pradhan, David Lim, Gary Call, Mark Dras   +7 more
doaj   +4 more sources